Shorter Hypofractionated Preoperative Radiotherapy Regimen for Soft-Tissue Sarcomas
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Hypofractionated, 3-week, preoperative radiotherapy for patients with soft tissue sarcomas (HYPORT-STS): a single-centre, open-label, single-arm, phase 2 trial
Lancet Oncol 2022 Nov 04;[EPub Ahead of Print], BA Guadagnolo, RL Bassett, D Mitra, A Farooqi, C Hempel, C Dorber, T Willis, WL Wang, R Ratan, N Somaiah, RS Benjamin, KE Torres, KK Hunt, CP Scally, EZ Keung, RL Satcher, JE Bird, PP Lin, BS Moon, VO Lewis, CL Roland, AJ BishopFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.